MétaCan
Menu
Back to cohort
Record W4408514756 · doi:10.1016/j.ejca.2025.115368

Conference on challenges in sarcoma (CCS) 2024: Expert opinions on non-evidence-based management aspects

2025· article· en· W4408514756 on OpenAlexaff
Silvia Höfer, Chantal Pauli, Beata Bode‐Lesniewska, Sylvie Bonvalot, Christina Fotopoulou, Hans Gelderblom, Rick L. Haas, Jendrik Hardes, Peter Hohenberger, Jens Jakob, Wolfgang G. Kunz, Andreas Leithner, Bernadette Liegl‐Atzwanger, Lars H. Lindner, Aisha Miah, Peter Reichardt, Piotr Rutkowski, Benedikt M. Schaarschmidt, Katrin Scheinemann, Joanna Szkandera, Eva Wardelmann, Dimosthenis Andreou, Christian Rothermundt

Bibliographic record

VenueEuropean Journal of Cancer · 2025
Typearticle
Languageen
FieldMedicine
TopicSarcoma Diagnosis and Treatment
Canadian institutionsInstitute of Cancer Research
FundersPharmaMar
KeywordsMedicine

Abstract

fetched live from OpenAlex

BACKGROUND: Soft tissue sarcomas (STS) and other mesenchymal tumours belong to rare, heterogeneous neoplasms with over 150 subtypes that pose significant challenges in diagnosis and clinical decision making. While guidelines address evidence-based diagnostic and therapeutic procedures, clinical situations and scenarios without evidence remain controversial in daily practice. The 2024 Conference on Challenges in Sarcoma (CCS2024) aimed to narrow these gaps with the support of an international and multidisciplinary panel of sarcoma experts. METHODS: A Delphi process identified 200 controversial questions across eight prioritised clinical scenarios, including tenosynovial giant cell tumour, synovial sarcoma of the extremities, retroperitoneal sarcomas, angiosarcoma, phyllodes tumour, malignant peripheral nerve sheath tumour, uterine leiomyosarcoma, and atypical lipomatous tumour. RESULTS: Sixty-four experts discussed 141 controversies during the conference and reached strong consensus (> 90 %) on 24 and consensus (> 75 %) on 45 key diagnostic and therapeutic issues, while unresolved controversies emphasized the need for further research. CONCLUSIONS: CCS2024 provides a framework for clinical decision making and underscores the importance of consensus-driven approaches in the treatment of rare and complex malignancies.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.125
metaresearch head score (Gemma)0.203
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Not applicable · Consensus signal: Not applicable
GenreCandidate signal: Commentary · Consensus signal: Commentary
Teacher disagreement score0.125
Threshold uncertainty score0.659

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.1250.203
Meta-epidemiology (narrow)0.0020.001
Meta-epidemiology (broad)0.0010.004
Bibliometrics0.0040.003
Science and technology studies0.0050.004
Scholarly communication0.0070.007
Open science0.0040.016
Research integrity0.0160.013
Insufficient payload (model declined to judge)0.0150.004

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.121
GPT teacher head0.364
Teacher spread0.242 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designNot applicable
Domainnot available
GenreCommentary

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations2
Published2025
Admission routes1
Has abstractyes

Explore more

Same venueEuropean Journal of CancerSame topicSarcoma Diagnosis and TreatmentFrench-language works237,207